Lista de estudios:

Estudiar 1:
Título: Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Cáncer de tiroides|Enfermedad de tiroides
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00341094

Estudiar 2:
Título: Mantenimiento con metadona & HIV Risk in Ukraine
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Opioid Dependence
Interventions: Droga: Metadona
URL: http://ClinicalTrials.gov/show/NCT00351026

Estudiar 3:
Título: Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) en Ucrania
Recruitment: Not yet recruiting
Study Results: No Results Available
Condiciones: HIV Infections|Intervention
Interventions: Behavioral: Peer Education Model|Behavioral: HIV Counseling and Education Model
URL: http://ClinicalTrials.gov/show/NCT01159704

Estudiar 4:
Título: Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Recruitment: Completed
Study Results: No Results Available
Condiciones: Leukemia
Interventions: Behavioral: Occupational Radiation Safety Standards
URL: http://ClinicalTrials.gov/show/NCT00341016

Estudiar 5:
Título: Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
Recruitment: Completed
Study Results: Has Results
Condiciones: Respiratory Tract Infections
Interventions: Droga: claritromicina (Klacid SR)
URL: http://ClinicalTrials.gov/show/NCT01095978

Estudiar 6:
Título: Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Studyy
Recruitment: Completed
Study Results: No Results Available
Condiciones: Cáncer de tiroides
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01265381

Estudiar 7:
Título: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Recruitment: Completed
Study Results: No Results Available
Condiciones: Advanced Prostate Cancer|Lower Urinary Tract Symptoms
Interventions: Droga: Leuprolide acetate Depot Susp. 11,25 mg (Polonia), 3,75 mg (Ucrania)
URL: http://ClinicalTrials.gov/show/NCT01078545

Estudiar 8:
Título: International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Environment
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00339274

Estudiar 9:
Título: Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: General Surgery
Interventions: Droga: sevoflurane
URL: http://ClinicalTrials.gov/show/NCT01282086

Estudiar 10:
Título: Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Recruitment: Enrolling by invitation
Study Results: No Results Available
Condiciones: TB|VIH
Interventions: Dietary Supplement: Immunoxel|Droga: Placebo|Droga: TB drugs+ Immunoxel|Droga: ATT+Placebo|Droga: ATT + Placebo|Droga: drug-resistant TB on ATT+Immunoxel|Droga: Immunoxel
URL: http://ClinicalTrials.gov/show/NCT01061593

Estudiar 11:
Título: Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Metastatic Breast Cancer
Interventions: Droga: Araxane versus Taxotere
URL: http://ClinicalTrials.gov/show/NCT00274456

Estudiar 12:
Título: Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
Recruitment: Completed
Study Results: No Results Available
Condiciones: Bronchial Asthma
Interventions: Droga: salbutamol 100 mcg|Droga: BDP/salbutamol HFA pMDI|Droga: BDP/salbutamol CFC pMDI
URL: http://ClinicalTrials.gov/show/NCT00528723

Estudiar 13:
Título: Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Recruitment: Completed
Study Results: Has Results
Condiciones: Bacterial Infections|Diabetic Foot|Osteomyelitis
Interventions: Droga: Tigecycline|Droga: Ertapenem
URL: http://ClinicalTrials.gov/show/NCT00366249

Estudiar 14:
Título: Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
Recruitment: Terminated
Study Results: No Results Available
Condiciones: Diabetes Mellitus
Interventions: Droga: PPM-204
URL: http://ClinicalTrials.gov/show/NCT00425919

Estudiar 15:
Título: Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause
Recruitment: Completed
Study Results: No Results Available
Condiciones: Menopause
Interventions: Droga: DVS-233
URL: http://ClinicalTrials.gov/show/NCT00195546

Estudiar 16:
Título: Tuberculosis (TB) Immunotherapy Phase 2 Estudiar
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Tuberculosis
Interventions: Biological: V7|Other: placebo
URL: http://ClinicalTrials.gov/show/NCT01380119

Estudiar 17:
Título: Russian Labor Migrant HIV Prevention Trial
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: VIH
Interventions: Behavioral: Social Network Intervention
URL: http://ClinicalTrials.gov/show/NCT01177995

Estudiar 18:
Título: Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
Recruitment: Not yet recruiting
Study Results: No Results Available
Condiciones: Metastatic Colorectal Cancer
Interventions: Droga: Irintoecan|Droga: HA-Irinotecan solution for Infusion
URL: http://ClinicalTrials.gov/show/NCT01290783

Estudiar 19:
Título: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple
Interventions: Droga: Teriflunomide (HMR1726)|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00622700

Estudiar 20:
Título: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Recruitment: Completed
Study Results: Has Results
Condiciones: Fibrilación auricular|Ataque
Interventions: Droga: warfarin|Droga: Dabigatran dose 1|Droga: Dabigatran dose 2
URL: http://ClinicalTrials.gov/show/NCT00262600

Estudiar 21:
Título: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Pulmonary Disease, Chronic Obstructive|Bronquitis crónica|Emphysema
Interventions: Droga: GSK573719/GW642444 125/25|Droga: GSK573719/GW642444 62.5/25|Droga: GW642444|Droga: tiotropium bromide
URL: http://ClinicalTrials.gov/show/NCT01316900

Estudiar 22:
Título: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Venous Thrombosis
Interventions: Droga: Enoxaparin|Droga: warfarin|Droga: Placebo for apixaban|Droga: Placebo for enoxaparin|Droga: Placebo for warfarin|Droga: apixaban
URL: http://ClinicalTrials.gov/show/NCT00643201

Estudiar 23:
Título: LOGiCLapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasias, Gastrointestinal Tract|Esophageal
Interventions: Droga: Lapatinib|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00680901

Estudiar 24:
Título: A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Major Depressive Disorder
Interventions: Droga: LY2216684|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01173601

Estudiar 25:
Título: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Recruitment: Completed
Study Results: Has Results
Condiciones: Osteoartritis|Artritis, Rheumatoid
Interventions: Droga: Celecoxib|Droga: diclofenaco + omeprazol
URL: http://ClinicalTrials.gov/show/NCT00141102

Estudiar 26:
Título: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Recruitment: Completed
Study Results: No Results Available
Condiciones: Venous Thrombosis|Pulmonary Embolism
Interventions: Droga: Apixaban|Droga: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00457002

Estudiar 27:
Título: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Artritis reumatoide|Artritis psoriásica|Espondiloartritis anquilosante
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01078402

Estudiar 28:
Título: The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: CV Risk|Aterosclerosis|Cardiovascular Disease|Coronary Heart Disease
Interventions: Droga: Darapladib|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00799903

Estudiar 29:
Título: Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Recruitment: Completed
Study Results: Has Results
Condiciones: Bacterial Pneumonia
Interventions: Droga: Ceftaroline fosamil for Injection|Droga: IV Ceftriaxone|Droga: Placebo|Droga: claritromicina
URL: http://ClinicalTrials.gov/show/NCT00621504

Estudiar 30:
Título: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Recruitment: Completed
Study Results: No Results Available
Condiciones: Diabetes Mellitus, Tipo 2
Interventions: Droga: aleglitazar|Droga: Actos
URL: http://ClinicalTrials.gov/show/NCT00461006

Estudiar 31:
Título: Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Condiciones: Esquizofrenia
Interventions: Droga: Placebo|Droga: RGH-188|Droga: RGH-188|Droga: RGH-188|Droga: risperidona
URL: http://ClinicalTrials.gov/show/NCT00694707

Estudiar 32:
Título: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Diabetes Mellitus, Tipo 2|Acute Coronary Syndrome
Interventions: Droga: Alogliptin|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00968708

Estudiar 33:
Título: Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Metastatic Colorectal Cancer
Interventions: Droga: Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)|Droga: Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
URL: http://ClinicalTrials.gov/show/NCT00865709

Estudiar 34:
Título: Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Recruitment: Completed
Study Results: No Results Available
Condiciones: Refractory Partial Seizures
Interventions: Droga: perampanel|Droga: perampanel|Droga: perampanel|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00700310

Estudiar 35:
Título: BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple
Interventions: Droga: laquinimod|Droga: placebo|Droga: Interferon β-1a (Avonex®)
URL: http://ClinicalTrials.gov/show/NCT00605215

Estudiar 36:
Título: Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Artritis, Rheumatoid|Osteoartritis
Interventions: Droga: celecoxib|Droga: Ibuprofen|Droga: Naproxen
URL: http://ClinicalTrials.gov/show/NCT00346216

Estudiar 37:
Título: Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Recruitment: Terminated
Study Results: No Results Available
Condiciones: Fibrilación auricular
Interventions: Droga: SSR126517E «biotinylated idraparinux»|Droga: warfarin
URL: http://ClinicalTrials.gov/show/NCT00580216

Estudiar 38:
Título: A Phase 3, Multicéntrico, Estudio de continuación de etiqueta abierta en sujetos asmáticos de moderados a graves que completaron el estudio FlutiForm HFA pMDI SKY2028-3-005
Recruitment: Completed
Study Results: No Results Available
Condiciones: Asma
Interventions: Droga: SKP FlutiForm HFA pMDI
URL: http://ClinicalTrials.gov/show/NCT00747318

Estudiar 39:
Título: Un estudio para evaluar la seguridad a largo plazo, Tolerabilidad y efecto del laquinimod oral diario 0.6 mg sobre la evolución de la enfermedad en sujetos con esclerosis múltiple recidivante
Recruitment: Enrolling by invitation
Study Results: No Results Available
Condiciones: Esclerosis múltiple recurrente
Interventions: Droga: laquinimod
URL: http://ClinicalTrials.gov/show/NCT01047319

Estudiar 40:
Título: Estudio de seguridad y eficacia de daclizumab HYP para tratar la esclerosis múltiple remitente-recurrente
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple, remitente-recurrente
Interventions: Droga: daclizumab HYP|Other: placebo
URL: http://ClinicalTrials.gov/show/NCT00390221

Estudiar 41:
Título: Un estudio en sujetos con esclerosis múltiple remitente-recurrente (RRMS) para evaluar la eficacia, Seguridad y tolerabilidad del acetato de glatiramero (Georgia) Inyección 40 mg administrados tres veces por semana en comparación con placebo
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple remitente recurrente
Interventions: Droga: acetato de glatiramero (Georgia)|Other: Placebo
URL: http://ClinicalTrials.gov/show/NCT01067521

Estudiar 42:
Título: TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Recruitment: Completed
Study Results: No Results Available
Condiciones: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Droga: TR-701 FA|Droga: Linezolid
URL: http://ClinicalTrials.gov/show/NCT01170221

Estudiar 43:
Título: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Recruitment: Completed
Study Results: No Results Available
Condiciones: Fibrilación auricular|Atrial Flutter
Interventions: Droga: Tedisamil sesquifumarate
URL: http://ClinicalTrials.gov/show/NCT00126022

Estudiar 44:
Título: Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Recruitment: Completed
Study Results: No Results Available
Condiciones: Bronchial Asthma
Interventions: Droga: Beclomethasone dipropionate|Droga: Beclomethasone dipropionate/Salbutamol combination|Droga: salbutamol
URL: http://ClinicalTrials.gov/show/NCT00497523

Estudiar 45:
Título: GSK1572932A Inmunoterapéutico contra el cáncer de antígeno específico como terapia adyuvante en pacientes con cáncer de pulmón de células no pequeñas
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Cáncer de pulmón de células no pequeñas con antígeno tumoral positivo|Cáncer de pulmón, Celda no pequeña
Interventions: Biological: GSK1572932A Inmunoterapéutico contra el cáncer específico de antígeno|Biological: Control placebo
URL: http://ClinicalTrials.gov/show/NCT00480025

Estudiar 46:
Título: Un estudio que compara la seguridad y eficacia de la combinación de fluticasona y formoterol (FlutiForm™) Con fluticasona o Flovent para tratar el asma de moderada a grave en adolescentes y adultos
Recruitment: Completed
Study Results: No Results Available
Condiciones: Asma
Interventions: Droga: FlutiForm 250/10|Droga: SKP-Fluticasona|Droga: Flovent Fluticasona HFA
URL: http://ClinicalTrials.gov/show/NCT00649025

Estudiar 47:
Título: Ensayo FRANCIS-ACS: Un estudio de la seguridad y eficacia de A 002 en sujetos con síndromes coronarios agudos
Recruitment: Completed
Study Results: No Results Available
Condiciones: Acute Coronary Syndrome
Interventions: Droga: Varespladib Metilo (A-002)
URL: http://ClinicalTrials.gov/show/NCT00743925

Estudiar 48:
Título: Un doble ciego, Controlado con placebo, 2-año Estudio sobre galantamina utilizada para tratar pacientes con enfermedad de Alzheimer de leve a moderada.
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Alzheimer Disease|Dementia, Alzheimer Type
Interventions: Droga: Galantamine|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00679627

Estudiar 49:
Título: The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Aterosclerosis|Acute Coronary Syndrome|Cardiovascular Disease|Coronary Heart Disease
Interventions: Droga: Darapladib 160 mg|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01000727

Estudiar 50:
Título: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Adolescent Schizophrenia|Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Interventions: Droga: Aripiprazol
URL: http://ClinicalTrials.gov/show/NCT01122927

Estudiar 51:
Título: PALMFlexS: Paliperidone Palmitate Flexible Dosing in Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Esquizofrenia
Interventions: Droga: Paliperidone Palmitate
URL: http://ClinicalTrials.gov/show/NCT01281527

Estudiar 52:
Título: MICHELANGELO OASIS-6 : Fondaparinux in ST Elevation Myocardial Infarction
Recruitment: Completed
Study Results: No Results Available
Condiciones: Myocardial Infarction|ST-elevation Myocardial Infarction|Acute Coronary Syndrome|Acute Myocardial Infarction
Interventions: Droga: FondaparinuxUFH indicated|Other: ControlUFH not indicated|Droga: fondaparinuxUFH not indicated|Droga: ControlUFH
URL: http://ClinicalTrials.gov/show/NCT00064428

Estudiar 53:
Título: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Recruitment: Completed
Study Results: No Results Available
Condiciones: Dyslipidemia/Glucose Metabolism Disorder
Interventions: Droga: fenofibrate and metformin combination (drug)
URL: http://ClinicalTrials.gov/show/NCT00349128

Estudiar 54:
Título: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Condiciones: Fibrilación auricular
Interventions: Droga: YM150|Droga: warfarina
URL: http://ClinicalTrials.gov/show/NCT00938730

Estudiar 55:
Título: Study of Paclitaxel in Patients With Ovarian Cancer
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
Interventions: Droga: Paclical®|Droga: Taxol®
URL: http://ClinicalTrials.gov/show/NCT00989131

Estudiar 56:
Título: Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Recruitment: Completed
Study Results: No Results Available
Condiciones: Hyperlipidemia
Interventions: Droga: fenofibrate / simvastatin|Droga: Atorvastatin
URL: http://ClinicalTrials.gov/show/NCT00362934

Estudiar 57:
Título: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Recruitment: Completed
Study Results: No Results Available
Condiciones: Fibrilación auricular
Interventions: Droga: Placebo|Droga: Vernakalant (oral)
URL: http://ClinicalTrials.gov/show/NCT00526136

Estudiar 58:
Título: Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
Recruitment: Completed
Study Results: No Results Available
Condiciones: Diabetes, Type I|Diabetes Type 2
Interventions: Droga: Technosphere Insulin|Droga: Cuidado usual|Other: Sin intervención
URL: http://ClinicalTrials.gov/show/NCT00308737

Estudiar 59:
Título: Ensayo clínico de la eficacia y seguridad del dipropionato de beclometasona más formoterol frente al propionato de fluticasona más salmeterol en el 6 Meses de tratamiento reducido del asma
Recruitment: Completed
Study Results: No Results Available
Condiciones: Asma
Interventions: Droga: Combinación fija de beclometasona más formoterol|Droga: Combinación fija de fluticasona más salmeterol
URL: http://ClinicalTrials.gov/show/NCT00497237

Estudiar 60:
Título: Comparación de tiotropio en HandhiHaler versus Respimat en la enfermedad pulmonar obstructiva crónica
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Pulmonary Disease, Chronic Obstructive
Interventions: Droga: tiotropio 2.5 mcg|Droga: tiotropio 5 mcg|Droga: tiotropio 18 mcg
URL: http://ClinicalTrials.gov/show/NCT01126437

Estudiar 61:
Título: Hidroclorotiazida como complemento de Olmesartán/Amlodipino en la hipertensión
Recruitment: Completed
Study Results: Has Results
Condiciones: Hipertensión esencial
Interventions: Droga: Olmesartán medoxomilo 40 mg – Amlodipino 10 mg|Droga: Olmesartán 40 mg-Amlodipino 10 mg-Hidroclorotiazida 12,5 mg|Droga: Olmesartán 40 mg-Amlodipino 10 mg-Hidroclorotiazida 25 mg|Droga: OLM 40 mg-AML 10 mg-Hidroclorotiazida 12,5 mg|Droga: OLM 40 mg-AML 10 mg-Hidroclorotiazida 12,5 mg|Droga: OLM 40 mg-AML 10 mg-Hidroclorotiazida 25 mg
URL: http://ClinicalTrials.gov/show/NCT00902538

Estudiar 62:
Título: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Tipo 2 Diabetes Mellitus
Interventions: Droga: Exenatide Once Weekly|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01144338

Estudiar 63:
Título: Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Recruitment: Completed
Study Results: No Results Available
Condiciones: Asma
Interventions: Droga: Fluticasone furoate/Vilanterol Inhalation Powder|Droga: Fluticasone Furoate Inhalation Powder|Droga: Placebo Inhaltion Powder
URL: http://ClinicalTrials.gov/show/NCT01165138

Estudiar 64:
Título: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Recruitment: Completed
Study Results: Has Results
Condiciones: Diabetes Mellitus, Tipo 2
Interventions: Droga: linagliptin|Droga: placebo
URL: http://ClinicalTrials.gov/show/NCT00621140

Estudiar 65:
Título: Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple, Relapsing-Remitting
Interventions: Droga: Daclizumab HYP|Droga: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT00870740

Estudiar 66:
Título: Phase III Acute Coronary Syndrome
Recruitment: Terminated
Study Results: No Results Available
Condiciones: Acute Coronary Syndrome
Interventions: Droga: Apixaban|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00831441

Estudiar 67:
Título: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Recruitment: Terminated
Study Results: No Results Available
Condiciones: Breast Neoplasms|Neoplasias, Hormone-Dependent
Interventions: Droga: Atamestane|Droga: Toremifene|Droga: Letrozole|Droga: Aromatase inhibition|Droga: Estrogen receptor blocker|Procedimiento: Hormone therapy|Procedimiento: Endocrine therapy|Procedimiento: Antiestrogen therapy
URL: http://ClinicalTrials.gov/show/NCT00097344

Estudiar 68:
Título: Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
Recruitment: Completed
Study Results: No Results Available
Condiciones: Asma
Interventions: Droga: Fluticasone Propionate 100mcg BD|Droga: GSK2190915 100mg|Droga: GSK2190915 10mg|Droga: GSK2190915 300mg|Droga: GSK2190915 30mg|Droga: Montelukast 10mg|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01147744

Estudiar 69:
Título: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma
Recruitment: Completed
Study Results: Has Results
Condiciones: Non-Hodgkin’s Lymphoma
Interventions: Droga: Bortezomib + Rituximab|Droga: Rituximab
URL: http://ClinicalTrials.gov/show/NCT00312845

Estudiar 70:
Título: TroVax Renal Immunotherapy Survival Trial
Recruitment: Completed
Study Results: No Results Available
Condiciones: Clear Cell Renal Carcinoma
Interventions: Biological: Trovax
URL: http://ClinicalTrials.gov/show/NCT00397345

Estudiar 71:
Título: PLASMA Trial: A Dose-Response Study of A-002 En sujetos con enfermedad arterial coronaria estable
Recruitment: Completed
Study Results: No Results Available
Condiciones: Arteriopatía coronaria (CANALLA)
Interventions: Droga: A-002
URL: http://ClinicalTrials.gov/show/NCT00455546

Estudiar 72:
Título: Prueba VISTA-16: Evaluación de la seguridad y eficacia de A a corto plazo-002 Tratamiento en sujetos con síndrome coronario agudo
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Acute Coronary Syndrome
Interventions: Droga: A-002, varespladib metil|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01130246

Estudiar 73:
Título: Estudio a largo plazo en monoterapia con acetato de eslicarbazepina
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Epilepsia
Interventions: Droga: acetato de eslicarbazepina
URL: http://ClinicalTrials.gov/show/NCT00910247

Estudiar 74:
Título: Efectividad y seguridad de dosis flexibles de paliperidona de liberación prolongada en pacientes adolescentes con esquizofrenia
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Esquizofrenia
Interventions: Droga: Aripiprazol|Droga: Paliperidona PR
URL: http://ClinicalTrials.gov/show/NCT01009047

Estudiar 75:
Título: Evento tromboembólico venoso (TEV) Profilaxis en pacientes médicamente enfermos
Recruitment: Completed
Study Results: No Results Available
Condiciones: Tromboembolismo venoso
Interventions: Droga: xarelto (Rivaroxabán, BAY59-7939)|Droga: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00571649

Estudiar 76:
Título: Estudio de fase III de ABI-007(Paclitaxel unido a albúmina) Más gemcitabina versus gemcitabina en el adenocarcinoma metastásico de páncreas
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Cáncer de páncreas metastásico
Interventions: Droga: Albumin-bound paclitaxel (ABI-007)/Gemcitabine|Droga: Gemcitabine
URL: http://ClinicalTrials.gov/show/NCT00844649

Estudiar 77:
Título: Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing Remitting Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Esclerosis múltiple, Relapsing-Remitting
Interventions: Droga: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT01051349

Estudiar 78:
Título: GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis
Recruitment: Completed
Study Results: No Results Available
Condiciones: Artritis reumatoide
Interventions: Droga: GLPG0259 oral capsule|Droga: Placebo|Droga: GLPG0259 (Part B)|Droga: Placebo (Part B)
URL: http://ClinicalTrials.gov/show/NCT01211249

Estudiar 79:
Título: A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Cancer After Chemotherapy
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Non-Small Cell Lung Cancer
Interventions: Droga: erlotinib [Tarceva]|Droga: Placebo|Droga: erlotinib [Tarceva]
URL: http://ClinicalTrials.gov/show/NCT01328951

Estudiar 80:
Título: Comparison of Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Tipo 1 Diabetes Mellitus
Interventions: Droga: Technosphere® Insulin with Gen2 Inhaler|Droga: Insulin aspart, basal insulin|Droga: Technosphere® Insulin with MedTone C Inhaler
URL: http://ClinicalTrials.gov/show/NCT01445951

Estudiar 81:
Título: Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Peripheral Arterial Occlusive Disease
Interventions: Droga: alprostadilo|Other: Placebo
URL: http://ClinicalTrials.gov/show/NCT00596752

Estudiar 82:
Título: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Recruitment: Completed
Study Results: Has Results
Condiciones: Hypertension
Interventions: Droga: fixed-dose combination of telmisartan 40mg+amlodipine 10mg|Droga: fixed-dose combination of telmisartan 80mg+amlodipine10mg
URL: http://ClinicalTrials.gov/show/NCT00624052

Estudiar 83:
Título: The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Condiciones: Esquizofrenia
Interventions: Droga: Cariprazine
URL: http://ClinicalTrials.gov/show/NCT00839852

Estudiar 84:
Título: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Recruitment: Completed
Study Results: Has Results
Condiciones: Trombosis, Venous|Superficial Thrombophlebitis
Interventions: Droga: Fondaparinux 2.5mg or placebo
URL: http://ClinicalTrials.gov/show/NCT00443053

Estudiar 85:
Título: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Schizoaffective Disorder
Interventions: Droga: Placebo|Droga: paliperidone palmitate
URL: http://ClinicalTrials.gov/show/NCT01193153

Estudiar 86:
Título: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Condiciones: Fibrilación auricular|Thromboembolism
Interventions: Droga: Edoxaban (DU-176b)|Droga: Edoxaban (DU-176b)|Droga: Edoxaban (DU-176b)|Droga: Edoxaban (DU-176b)|Droga: warfarin
URL: http://ClinicalTrials.gov/show/NCT00504556

Estudiar 87:
Título: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Recruitment: Completed
Study Results: No Results Available
Condiciones: Acne Vulgaris
Interventions: Droga: Valette|Droga: Diane|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT00280657

Estudiar 88:
Título: LurasidoneA 24-week Extension Study of Patients With Bipolar I Depression
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Bipolar|Depresión
Interventions: Droga: lurasidone
URL: http://ClinicalTrials.gov/show/NCT00868959

Estudiar 89:
Título: PRoFESSPrevention Regimen For Effectively Avoiding Second Strokes
Recruitment: Completed
Study Results: Has Results
Condiciones: Cerebrovascular Accident
Interventions: Droga: extended-release dipyridamole + aspirina|Droga: clopidogrel|Droga: telmisartán
URL: http://ClinicalTrials.gov/show/NCT00153062

Estudiar 90:
Título: Combinación de dosis fija de telmisartán y amlodipino [FDC] Ensayo para el tratamiento de la hipertensión grave
Recruitment: Completed
Study Results: Has Results
Condiciones: Hypertension
Interventions: Droga: amlodipino|Droga: telmisartán|Droga: telmisartán y amlodipino
URL: http://ClinicalTrials.gov/show/NCT00860262

Estudiar 91:
Título: Seguridad y eficacia de la monoterapia con acetato de eslicarbazepina en sujetos con epilepsia parcial no bien controlada con los fármacos antiepilépticos actuales
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Epilepsia
Interventions: Droga: acetato de eslicarbazepina 1600 mg|Droga: acetato de eslicarbazepina 1200 mg
URL: http://ClinicalTrials.gov/show/NCT01091662

Estudiar 92:
Título: Prevención de eventos cardiovasculares (p.ej, Muerte por enfermedad cardíaca o vascular, Infarto de miocardio, o accidente cerebrovascular) en pacientes con ataque cardíaco previo que usan ticagrelor en comparación con placebo en un contexto de aspirina
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Myocardial Infarction|Muerte cardiovascular|aterotrombosis|Ataque
Interventions: Droga: ticagrelor 90 mg|Droga: ticagrelor 60 mg|Droga: Ticagrelor Placebo
URL: http://ClinicalTrials.gov/show/NCT01225562

Estudiar 93:
Título: Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Multiple Myeloma
Interventions: Droga: Thalidomide and Dexamethasone|Droga: dexametasona
URL: http://ClinicalTrials.gov/show/NCT00057564

Estudiar 94:
Título: Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Leukaemia, Lymphocytic, Crónico|Chronic Lymphocytic Leukemia
Interventions: Droga: OFC Infusion|Droga: FC infusion
URL: http://ClinicalTrials.gov/show/NCT00824265

Estudiar 95:
Título: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Recruitment: Completed
Study Results: No Results Available
Condiciones: Cystic Fibrosis
Interventions: Droga: tobramycin|Droga: tobramycin
URL: http://ClinicalTrials.gov/show/NCT00885365

Estudiar 96:
Título: Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Esquizofrenia
Interventions: Droga: Cariprazine|Droga: Cariprazine|Droga: Aripiprazol|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01104766

Estudiar 97:
Título: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Recruitment: Completed
Study Results: Has Results
Condiciones: Hypertension
Interventions: Droga: fixed dose combination of telmisartan+amlodipine|Droga: amlodipino
URL: http://ClinicalTrials.gov/show/NCT00553267

Estudiar 98:
Título: Fenofibrate and Metformin Fixed Combination vs RosiglitazoneFAME ROSI
Recruitment: Terminated
Study Results: No Results Available
Condiciones: Dyslipidemia|Glucose Metabolism Disorder
Interventions: Droga: fenofibrate (F) + metformin (M) hydrochloride fixed combination|Droga: Rosiglitazone
URL: http://ClinicalTrials.gov/show/NCT00361868

Estudiar 99:
Título: Safety and Efficacy of Cariprazine for Bipolar I Disorder
Recruitment: Recruiting
Study Results: No Results Available
Condiciones: Mania|Bipolar I Disorder
Interventions: Droga: Cariprazine low dose|Droga: Cariprazine high dose|Droga: Placebo
URL: http://ClinicalTrials.gov/show/NCT01058668

Estudiar 100:
Título: A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Recruitment: Activo, not recruiting
Study Results: No Results Available
Condiciones: Fibrilación auricular
Interventions: Droga: Apixaban|Droga: Acetylsalicylic Acid (ASA)|Droga: Apixaban
URL: http://ClinicalTrials.gov/show/NCT00496769


NB Ciencia

organización de contratos de investigación

terapia con células madre